Prazaxa is a chemical compound used as an active pharmaceutical ingredient in pharmaceutical manufacturing. It is a highly flexible molecule with a complex structure containing multiple aromatic rings and functional groups, reflecting its role as a specialized pharmaceutical intermediate.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 211915-06-9
Pradaxa
pharmaceutical raw material
Dabigatran etexilate mesylate
pharmaceutical raw material
Ethyl 3-((2-((4-(N-hexoxycarbonylcarbamimidoyl)-N-nitrosoanilino)methyl)-1-methylbenzimidazole-5-carbonyl)-pyridin-2-ylamino)propanoate
pharmaceutical raw material
Dabigatran impurity P
pharmaceutical intermediate
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride
pharmaceutical raw material
Asciminib hydrochloride
pharmaceutical raw material
Calcitonin human
pharmaceutical raw material
(3ss)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol-d4; CB 7598-d4;
pharmaceutical raw material
ethyl 3-[[2-[[4-(N-hexoxycarbonylcarbamimidoyl)anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate
KSGXQBZTULBEEQ-UHFFFAOYSA-N
CCCCCCOC(=O)NC(=N)C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4